SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial

por Karg, M. V., Bosch, A., Kannenkeril, D., Striepe, K., Ott, C., Schneider, M. P., Boemke-Zelch, F., Linz, P., Nagel, A. M., Titze, J., Uder, M., Schmieder, R. E.
Publicado 2018